Research Article

Free Testosterone Reflects Metabolic as well as Ovarian Disturbances in Subfertile Oligomenorrheic Women

Table 1

Biochemistry, hyperandrogenism, metabolic and ovarian parameters, and PCOS diagnosis for 66 women with oligomenorrhea.

Mean (SD) or (%)Reference intervalLimit of quantification

Age28.3 (3.0)
Biochemistry
 Total T (ng/dL)46.5 (23.7)≤412.5
 A4 (ng/dL)180 (90)≤2402.5
 Free T (ng/dL)0.57 (0.37)≤0.49
 SHBG (nmol/L)70.1 (32.6)41–1032.0
 E2 (ng/L)59.2 (50.6)15–3501.3
 E1 (ng/L)61.9 (33.4)17–2001.2
 LH (U/L)9.4 (4.8)2.4–12.60.1
 FSH (U/L)5.8 (1.3)3.5–12.50.1
 LH/FSH1.6 (0.9)
 DHEAS (μg/dL)212 (91)98.8–3400.1
 AMH (ng/mL)8.4 (5.4)1.0–9.50.03
Clinical hyperandrogenism
 Hirsutism score2.1 (2.4)<3
 Having hirsutism21 (33%)
 Having acne28 (44%)
Metabolic parameters
 BMI25.0 (5.2)18.5–24.9
  % normal BMI36 (54.6%)
  % overweight21 (31.8%)
  % obese9 (13.6%)
 Waist circumference (cm)86.4 (13.3)<80
 Glucose (mg/dL)92.2 (15.7)80–1102
 Insulin (pmol/L)67.4 (40.6)17.8–1730.3
 HOMA-IR1.25 (0.74)
 Total cholesterol (mg/dL)174.6 (29.6)≤1903.9
 HDL cholesterol (mg/dL)52.0 (14.2)≥453.1
 LDL cholesterol (mg/dL)104.6 (25.0)≤115
 Triglycerides (mg/dL)90.1 (50.2)≤1508.8
Ovarian ultrasound parameters ()
 Mean ovarian volume (mL)10.0 (4.1)≤10
 Mean number of antral follicles31.0 (14.8)<12
 Follicle localization
  Random29 (59%)
  Peripheral18 (37%)
  Random and peripheral2 (4%)
 Follicle size
  Uniform16 (37%)
  Nonuniform27 (63%)
 % of women meeting PCOM criteria49 (92%)
PCOS diagnosis ()
 Having PCOS49 (92%)
  Oligomenorrhea + PCOM + high total T24 (49%)
  Oligomenorrhea + PCOM + normal total T25 (51%)

For ultrasound parameters and PCOS definition: 13 patients were additionally excluded (see Methods). Total T: total testosterone; A4: androstenedione; E2: estradiol; E1: estrone; free T: calculated free testosterone; SHBG: sex hormone-binding globulin; LH: luteinizing hormone; FSH: follicle-stimulating hormone; DHEAS: dehydroepiandrosterone sulphate; AMH: anti-Mullerian hormone; BMI: body mass index; HOMA-IR: homeostasis model assessment of insulin resistance; PCOM: polycystic ovary morphology.